文献速递心脑血管急症重症综合管理与镇静镇痛

血浆高敏C反应蛋白/白蛋白比值对急性冠脉综合征患者死亡的预测价值

[Predictive value of plasma high-sensitivity C-reactive protein/albumin ratio for the death in patients with acute coronary syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论ACS患者入院HCRP/ALB>0.246时住院死亡率10.4% vs 1.4%,HCRP/ALB是死亡的独立危险因素(OR=3.835)。

该回顾性研究纳入2018年1月至2020年8月首都医科大学附属北京安贞医院收治的1722例ACS患者(含UA、NSTEMI、STEMI),按住院结局分为死亡组(74例)与存活组。死亡组心率、HCRP、BNP、HCRP/ALB均高于存活组,ALB更低(均P<0.01)。ROC曲线显示HCRP/ALB预测死亡的AUC为0.803(95%CI 0.738-0.869),约登指数0.559对应HCRP/ALB=0.246。多因素logistic回归显示高HCRP/ALB(OR=3.835,95%CI 1.612-9.125,P=0.002)与高心率(OR=1.037,95%CI 1.020-1.055,P=0.000)为独立危险因素,高ALB可降低死亡风险(OR=0.884,95%CI 0.818-0.957,P=0.002)。作者认为HCRP/ALB可作为ACS患者死亡风险的有效预测指标。

要点

  • 1722例ACS患者中住院死亡74例,死亡组HCRP/ALB为0.700(0.289, 1.017),存活组为0.089(0.026, 0.368),P<0.01。
  • HCRP/ALB预测住院死亡的AUC为0.803(95%CI 0.738-0.869),约登指数0.559对应截断值0.246。
  • 以0.246为界分组,高HCRP/ALB组(>0.246,559例)住院死亡率为10.4%,低HCRP/ALB组(≤0.246,1163例)为1.4%(P<0.01)。
  • 多因素logistic回归显示高HCRP/ALB是死亡的独立危险因素(OR=3.835,95%CI 1.612-9.125,P=0.002),高心率OR=1.037(95%CI 1.020-1.055,P=0.000)。
  • 高ALB可降低ACS患者死亡率(OR=0.884,95%CI 0.818-0.957,P=0.002)。

适用人群与场景

  • 2018年1月至2020年8月首都医科大学附属北京安贞医院收治的急性冠脉综合征(ACS)患者,包括不稳定型心绞痛(UA)、非ST段抬高型心肌梗死(NSTEMI)、ST段抬高型心肌梗死(STEMI)。

诊断标准与关键阈值

  • HCRP/ALB截断值0.246(约登指数0.559对应值):HCRP/ALB≤0.246为低HCRP/ALB组(1163例),HCRP/ALB>0.246为高HCRP/ALB组(559例)。

研究设计与关键结果

  • 研究类型:回顾性分析,单中心(首都医科大学附属北京安贞医院),纳入1722例ACS患者,住院期间死亡74例。
  • 死亡组与存活组比较:心率(次/分)89±19 vs 73±15,HCRP(mg/L)23.24(9.79, 33.69)vs 3.57(1.03, 14.26),BNP(ng/L)424.0(164.3, 1596.1)vs 79.0(31.0, 211.4),HCRP/ALB 0.700(0.289, 1.017)vs 0.089(0.026, 0.368),均P<0.01;ALB(g/L)35.37±5.16 vs 39.97±6.43,P<0.01;除高脂血症发生率外,其他基线数据差异有统计学意义。
  • ROC曲线分析:BNP预测死亡的AUC(95%CI)为0.781(0.717-0.845),HCRP为0.790(0.724-0.856),HCRP/ALB为0.803(0.738-0.869)。
  • 高HCRP/ALB组(>0.246)与低HCRP/ALB组(≤0.246)比较:住院死亡率10.4% vs 1.4%(P<0.01),主动脉内球囊反搏(IABP)植入率12.7% vs 2.7%(P<0.01),BNP(ng/L)253.0(82.8, 749.0)vs 60.0(26.0, 145.2),HCRP(mg/L)25.42±17.47 vs 2.62±2.43,HCRP/ALB 0.700±0.435 vs 0.066±0.062,均P<0.01;ALB(g/L)36.89±4.30 vs 41.17±6.83,P<0.01;除性别、既往吸烟、高血压和糖尿病发生率外,其他基线数据差异有统计学意义。
  • 多因素logistic回归:高心率OR=1.037(95%CI 1.020-1.055,P=0.000)和高HCRP/ALB(OR=3.835,95%CI 1.612-9.125,P=0.002)是ACS患者死亡的独立危险因素;高ALB可降低死亡率(OR=0.884,95%CI 0.818-0.957,P=0.002)。

证据类型、等级与局限

  • 证据类型:回顾性分析(单中心)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为HCRP/ALB可作为ACS患者死亡风险的有效预测指标;HCRP/ALB越高,ACS患者死亡风险越高,当HCRP/ALB大于0.246时患者死亡率更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the predictive value of plasma high-sensitivity C-reactive protein/albumin ratio (HCRP/ALB) for the death in patients with acute coronary syndrome (ACS).

METHODS: The clinical data of patients with ACS [including unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), ST segment elevation myocardial infarction (STEMI)] admitted to Beijing Anzhen Hospital Affiliated to Capital Medical University from January 2018 to August 2020 were retrospectively analyzed. The plasma HCRP and ALB were recorded and the HCRP/ALB ratio was calculated. Patients were divided into death group and survival group according to the hospital outcome. The differences of baseline data and biochemical indexes between the two groups were compared. Receiver operating characteristic curve (ROC curve) was used to analyze the predictive value of each variable to death. Logistic regression was used to analyze the risk factors of death.

RESULTS: Among the 1 722 ACS patients, 74 died in hospital. Comparison of baseline data between death group and survival group showed that the other baseline data were statistically different except for the rate of hyperlipidemia. Among them, patients in death group had higher heart rate (HR), HCRP, B-type natriuretic peptide (BNP), HCRP/ALB [HR (bpm): 89±19 vs. 73±15, HCRP (mg/L): 23.24 (9.79, 33.69) vs. 3.57 (1.03, 14.26), BNP (ng/L): 424.0 (164.3, 1 596.1) vs. 79.0 (31.0, 211.4), HCRP/ALB: 0.700 (0.289, 1.017) vs. 0.089 (0.026, 0.368), all P < 0.01], while ALB was lower (g/L: 35.37±5.16 vs. 39.97±6.43, P < 0.01). ROC curve analysis showed that area under ROC curve and 95% confidence interval [AUC (95%CI)] of BNP, HCRP and HCRP/ALB for predicting death were 0.781 (0.717-0.845), 0.790 (0.724-0.856) and 0.803 (0.738-0.869), respectively. The Youden index of HCRP/ALB was 0.559, and the corresponding HCRP/ALB was 0.246. The patients were divided into low HCRP/ALB group (HCRP/ALB ≤ 0.246, 1 163 cases) and high HCRP/ALB group (HCRP/ALB > 0.246, 559 cases). Except for gender, previous smoking, hypertension and diabetes rates, the other baseline data were statistically different between the two groups. Patients in the high HCRP/ALB group had a higher mortality (10.4% vs. 1.4%, P < 0.01), higher rates of implanted intra-aortic balloon pump (IABP, 12.7% vs. 2.7%, P < 0.01), higher BNP, HCRP, HCRP/ALB [BNP (ng/L): 253.0 (82.8, 749.0) vs. 60.0 (26.0, 145.2), HCRP (mg/L): 25.42±17.47 vs. 2.62±2.43, HCRP/ALB: 0.700±0.435 vs. 0.066±0.062, all P < 0.01], while lower ALB (g/L: 36.89±4.30 vs. 41.17±6.83, P < 0.01). Logistic regression analysis showed that higher HR [odds ratio (OR) = 1.037, 95%CI was 1.020-1.055, P = 0.000] and higher HCRP/ALB (OR = 3.835, 95%CI was 1.612-9.125, P = 0.002) were independent risk factors for the death in ACS patients, while higher ALB could reduce the mortality in ACS patients (OR = 0.884, 95%CI was 0.818-0.957, P = 0.002).

CONCLUSIONS: The higher the HCRP/ALB, the higher the risk of death in patients with ACS. When HCRP/ALB is greater than 0.246, the patient has a higher mortality. Therefore, HCRP/ALB in patients with ACS can be used as an effective predictor for death risk.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang N, Liu W, Kang Y, et al. [Predictive value of plasma high-sensitivity C-reactive protein/albumin ratio for the death in patients with acute coronary syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34112295. doi:10.3760/cma.j.cn121430-20201127-00736

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。